oncnursingnews7h
Digital Health Tool Helps Patients With Prostate Cancer During Consultations
MyCareGorithm was met with high approval from patients, companions, and physicians, with all 3 groups reporting they’d ...
oncnursingnews1h
Barry Goy, MD
Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.
oncnursingnews2h
Benefits, Risks With EBRT Plus SADT in Intermediate-Risk Prostate Cancer
Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.
oncnursingnews3h
Enfortumab Vedotin May Be Safe in Ultra-Elderly Patients With Urothelial Carcinoma
Findings also suggested that an up-front dose reduction of enfortumab vedotin may benefit older patients with urothelial carcinoma.
oncnursingnews9h
Referral Process: Best Practices for Clear Communication
Dr Mohan discusses with Nurse Goff, Dr Mohan, and Dr Nadeem strategies for maintaining continuity of care and communication between community centers and academic institutions during bispecific ...
oncnursingnews9h
Referring Patients on Bispecific Therapy: Initial Steps
Dr Mohan discusses with Dr Nadeem, Dr Mann, and Nurse Distaso the key factors for referring patients from community centers to academic institutions for bispecific therapy and strategies for ...